CClinicalTrials.gg
CompletedNCT03027141Updated Feb 27, 2026

Self-Face Recognition After Face Transplantation

An interventional study of Face recognition task in Disfigurement of Face, sponsored by NYU Langone Health. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Non-randomized
Sex
All
01

Study summary

The purpose of the proposed study is to use functional magnetic resonance imaging (fMRI) to investigate how a change in facial appearance is initially represented in brain circuits and then alters over time, as the new face becomes recognized as "me".

Investigators will try to identify areas of the brain responsible for processing and storing information about self-facial recognition; Examine how these areas of the brain respond to images of "self" and "non-self" and; Investigate how the brain responds, over time, to changes in facial recognition, particularly at time points: i) prior to facial injury, ii) post-injury but prior to facial transplantation, and iii) after receiving facial transplantation.

Read the detailed description

Before surgery, investigators will compare activity in the brain when participants are looking at their pre-injury and their injured face with activity when they are looking at the persons face with whom they are familiar with. This will identify whether there are differences between how the brain responds when patients view their current facial appearance and when viewing their face before facial disfigurement. Investigators will then scan the patients post-operatively when the transplant team deems the patient ready; this will depend on reduction of post-operative swelling, improved communication with the treatment team, and patient psychological status. Activity in the brain will be compared when participants are looking at pictures of the familiar other person, with pictures of their pre-injury, pre-transplant disfigured face and pictures of their post-transplant facial appearance. Participants will be scanned again, at least two months later, with the same set of stimuli. Activity in the brain will be compared when participants look at their pre-transplant disfigured face and their new face, compared with activity when they look at the familiar other. This will allow investigators to see the differences in how the brain responds to the new facial appearance over time.

02

Conditions studied

  • Disfigurement of Face

Keywords

  • Face Transplant
03

In context

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who have suffered from severe facial disfigurement which warrant facial transplantation and have been evaluated and approved for transplantation, will be included.

Exclusion criteria

Exclusion Criteria:

  • Must be be able to enter and be scanned using MRI.
  • Able to give full informed consent, before each scan and throughout their time in which they are participating in the study
  • Able to perform the task to a high standard and also to have no underlying conditions that may alter how they process pictures of face
  • Participants must have none of the following, which cannot safely be removed without risk or discomfort while they enter the MRI unit:

    • a pacemaker
    • metal implants
    • metal that cannot be removed on their body (e.g. shrapnel, piercings)
    • metal clips
    • an artificial heart valve
    • a cochlear implant
    • drug patches
    • a contraceptive coil
    • dental plates/braces with metal in
    • hearing aids
  • Participants will also be excluded on the grounds of safety and comfort inside the MRI scanner if they have one of the following underlying conditions

    • epilepsy
    • diabetes
    • heart disease
    • thermoregulatory problems (problems regulating body temperature)
    • a possibility of being pregnant
    • currently breastfeeding
  • Participants will also be excluded on the grounds of MRI data quality for the following reasons:

    • history of mental illness
    • claustrophobia (discomfort in confined spaces)
    • Neurological conditions
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Active comparator
    Pre-Transplant Time Point

    Participants will be imaged in the Magnetic Resonance Imaging scanner (MRI)

    Behavioral: Face recognition task

  • Experimental
    Post-Transplant Time Point

    Participants will be imaged in the Magnetic Resonance Imaging scanner (MRI). Patients for whom a pre-transplant fMRI was obtained will undergo functional MRI scanning at three-points post-transplant (approximately 2 and 4 months +/- 2 months post-operation and again at 1 year +/- 3 months post-transplant).

    Behavioral: Face recognition task

Interventions

  • BehavioralFace recognition task

    Inside the MRI scanner and during the experiment, participants will be asked to make judgments about the identity they perceived in each morphed picture.

06

What researchers measure

Primary outcomes

  1. Average percentage of the self in the morphs that participants judge to be "like self" for the self- face before disfigurement,

    This will be done by means of a series of repeated-measures analyses of variance (ANOVA statistical tests) using a computer program - the Statistical Package for the Social Sciences

    Time frame: 5 Years

  2. Average percentage of the self in the morphs that participants judge to be "like self" for the self- face before before surgery

    This will be done by means of a series of repeated-measures analyses of variance (ANOVA statistical tests) using a computer program - the Statistical Package for the Social Sciences

    Time frame: 5 Years

  3. Average percentage of the self in the morphs that participants judge to be "like self" for the self- face after surgery.

    This will be done by means of a series of repeated-measures analyses of variance (ANOVA statistical tests) using a computer program - the Statistical Package for the Social Sciences

    Time frame: 5 Years

07

Study locations

1 site
  • New York University School of Medicine
    New York, New York 10016, United States
08

References and documents

Publications

  • Azevedo RT, Diaz-Siso JR, Alfonso AR, Ramly EP, Kantar RS, Berman ZP, Diep GK, Rifkin WJ, Rodriguez ED, Tsakiris M. Re-cognizing the new self: The neurocognitive plasticity of self-processing following facial transplantation. Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2211966120. doi: 10.1073/pnas.2211966120. Epub 2023 Mar 27. PubMed 36972456 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03027141
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Jan 20, 2017
Start date
Feb 1, 2017
Primary completion
Dec 10, 2025
Completion
Dec 10, 2025
Last update
Feb 27, 2026

Study contacts

Eduardo Rodriguez
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion